ArticleBiology2026
Chitosan and Chitosan Oligosaccharide Enhance Cryopreservation of Rabbit Testicular Tissue.
Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Testicular tissue cryopreservation is a key strategy for preserving fertility in adult males, yet optimal cryoprotective protocols have yet to be established. This study evaluated the effects of varying concentrations of chitosan oligosaccharide (COS, 0-25%) and chitosan (CS, 0-25%) on rabbit testicular tissues. Right testes from 35 male New Zealand rabbits were assigned to COS groups and left testes to CS groups. Each group was further divided into seven subgroups: fresh control, 0% control, and 5%, 10%, 15%, 20%, and 25% treatment groups. After one month of slow freezing, tissues were assessed by histomorphological scoring (cell swelling, cell loss, basement membrane integrity, and seminiferous tubule architecture) and seminiferous tubule diameter measurement. The 20% COS group achieved the highest histomorphological score, significantly exceeding the 0% control and comparable to the fresh control. Among CS treatments, the 15% group yielded the best score, also significantly higher than the 0% control. All frozen groups exhibited significantly reduced seminiferous tubule diameters compared with the fresh control, and these diameter changes did not correlate with the morphological scores. Concentrations exceeding the optimal level led to lose tubular structure and severe exfoliation of epithelial cells, suggesting that excessive osmotic stress may have contributed to the observed structural damage. COS demonstrated superior cryoprotection compared with CS under the present experimental conditions, which may be attributed to its lower molecular weight and improved diffusibility. These findings indicate that COS may represent a promising candidate for optimizing polysaccharide-based cryoprotectants in testicular tissue banking, although further functional validation is required.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.